Skip to content

CLLS

Cellectis SA

NASDAQ · Healthcare · Biotechnology · FR

$1.53
+4.79%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
1.57x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
3.75x
Price / sales
2.72x
Price / cash flow
-3.68x

Enterprise value

Enterprise value
$71.8M
EV / sales
1.27x
EV / EBITDA
-1.29x
EV / EBIT
-1.16x
Market cap
$154.1M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026